首药控股（北京）股份有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 上市公司 Size: 100-499人 Founded: 10年
Industry: 制药/生物工程
Full name: 首药控股（北京）股份有限公司。

Development Stage

Stage: IPO上市, , 上交所。
Ranking: Ranked #31 in 北京创新药物公司 by popularity Ranked #32 in 北京原研药公司 by popularity Ranked #36 in 北京创新药公司 by popularity Ranked #90 in 北京药物研发公司 by popularity
Honors: 2025中国化药研发实力100强高新技术企业瞪羚企业 According to algorithm
News: 2021-08-03：上交所：首药控股科创板首发获通过。
Salary: 55.7% of positions earn 30-50K以上, In 2026 vs last yeargrew by 6%.。Master's salary: ¥32.0K, Doctorate salary: ¥43.1K.
R&D: "生物/制药/化工/环保类" demand: 38.6%, "医疗卫生/美容保健类": 37.1%, "其他（研发和技术类）": 28.6%。
Recruiting: In 2026 vs 2025grew by 40%. Demand for highly educated talent: Master's: 7, Doctorate: 8.
Requirement: Education: 本科 leads with 44%. Experience: 5-10年 leads with 44%.
Region: Distributed across 1 regions, 北京: 96%, 成都: 2.7%, 沈阳: 1.3%.

About the Company

[Summary] 专注于肿瘤和糖尿病一类新药的研发和生产。

首药控股(北京）股份有限公司成立于2016年4月19日，是由市、区两级国有资金参股的混合所有制高新技术企业。公司总部位于北京亦庄经济技术开发区景园街，专注于具有自主知识产权的创新药的研发和生产。公司奉行绩效原则，注重经验和品格，在创新药方面将不可能成为了可能。首药控股目前已于全球范围内获发明专利授权逾百项，获得国家一类新药临床批件17个（包括合作研发项目），荣获国家“十二五”“十三五”重大新药创制专项8项。目前，已有2个新药进入临床III期、2个新药进入临床II期、12个新药进入临床I期。创好药、造中国患者能够用得起的一类新药，是首药控股人的追求。让我们在“责、权、利”清晰又扛得住的机制里，撸起袖子加油干，把首药控股锻造成为集研发、生产、销售于一体的国际化药企。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

首药控股 News (1 items)

Manage

上交所：首药控股科创板首发获通过

From 36kr 2021-08-03 18:15:46

首药控股 Financing History (1 rounds)

Manage

IPO上市

Capital Market Favor

Latest Financing Round

Date: ?
Market:
Deal: 上交所

首药控股 How Fast Is Hiring Growing? (28 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Down 35%
2024: Up 44%
2023: Down 28%
2022: Up 43%

首药控股 Year-by-Year Hiring:

2021 42 jobs 2022 60 jobs 2023 43 jobs 2024 62 jobs 2025 40 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

Beijing 27 Shenyang 1

首药控股 Campus Recruitment & Advanced Degree Talent Demand

Master's 7 Doctorate 8

首药控股 Latest Jobs

Note: How fast is hiring at 首药控股（北京）股份有限公司 growing? 首药控股2025: 40 openings (down 35%), 2024: 62 openings (up 44%), 2023: 43 openings (down 28%), 2022: 60 openings (up 43%), 2021: 42 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

首药控股 Master's Degree Job Demand Analysis

(More)

Growth Rate

2026 vs 2025

2025: Down 7%
2024: Up 56%
2023: Down 47%
2022: Up 89%

首药控股 Master's Hiring by Year:

2021 9 jobs 2022 17 jobs 2023 9 jobs 2024 14 jobs 2025 13 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at 首药控股（北京）股份有限公司 growing? 首药控股Master's recruitment over the years: 2025: 13 openings (down 7%), 2024: 14 openings (up 56%), 2023: 9 openings (down 47%), 2022: 17 openings (up 89%), 2021: 9 openings.

首药控股 Doctoral Degree Job Demand Analysis

(More)

+14%

Growth Rate

2026 vs 2025

2025: Up 100%
2024: Up 17%
2023: Down 40%
2022: Up 100%

首药控股 Doctoral Hiring by Year: 2026 — 2 more jobs than 2025

2021 5 jobs 2022 10 jobs 2023 6 jobs 2024 7 jobs 2025 14 jobs 2026 16 jobs

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Doctoral Salary 򀀩

How fast is doctoral hiring at 首药控股（北京）股份有限公司 growing? 首药控股Doctorate recruitment over the years: 2026: 16 openings (up 14%), 2025: 14 openings (up 100%), 2024: 7 openings (up 17%), 2023: 6 openings (down 40%), 2022: 10 openings (up 100%), 2021: 5 openings.

首药控股 R&D Strength (Technical Talent Demand)

(More)

生物/制药/化工/环保类: 27 roles, 38.6% of total. Hot jobs:

How is the demand for technical talent at 首药控股（北京）股份有限公司? Based on an analysis of 首药控股's job postings over the past year, "生物/制药/化工/环保类" demand: 38.6%, "医疗卫生/美容保健类": 37.1%, "其他（研发和技术类）": 28.6%, "科研类": 18.6%, "计算机/网络/技术类": 7.1%, "美术/设计/创意类": 4.3%. For reference only.

首药控股 — What Are the Salaries Like? (70 records)

Manage

首药控股 Salary Overview

salary range: 6K - 50K, 55.7% of roles pay ￥30-50K以上

4.3% 6-8K 12.9% 10-15K 12.9% 15-20K 14.3% 20-30K ***  ? 30-50K ***  ? 50K以上

Note: salary statistics are based on 70 salary records from the past year and depend on the job sample. For reference only.

首药控股 Salary Ranking

By Category

经营管理类￥42.1K  生物/制药/化工/环保类  医疗卫生/美容保健类  其他（研发和技术类）  科研类 

How is the salary at 首药控股（北京）股份有限公司?首药控股55.7% of positions earn 30-50K以上, Fresh graduate salary: ¥7.0K。Beijing salary ranking: #517，经营管理类 average salary ¥42.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 首药控股

(More)

Are salaries high at 首药控股（北京）股份有限公司? We provide: 研究员，副总，研发人员，销售，车间，高级经理，cad，临床，毒理总监，设计总，分析，化学，合规，地区经理，工人，开发经理，招聘经理，操作工，研究助理，药物制剂. Click to view detailed salary analysis by job.

首药控股 — Fortune 500? (More)

Yes, ranked in 中国化药研发实力100强:

NO.92 2025中国化药研发实力100强 >

首药控股 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

首药控股 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

经营管理类
50.7% of total 50.7%
生物/制药/化工/环保类
42.7% of total 42.7%
医疗卫生/美容保健类
37.3% of total 37.3%
其他（研发和技术类）
30.7% of total 30.7%

Job Location

Education

本科
44% of total 44%
博士
32% of total 32%
硕士
18.7% of total 18.7%
大专
5.3% of total 5.3%

Experience

5-10年
44% of total 44%
不限
25.3% of total 25.3%
3-5年
16% of total 16%
1-3年
13.3% of total 13.3%

View Detailed Analysis

What does 首药控股（北京）股份有限公司 require? Who is 首药控股 hiring? 首药控股 recruitment: 经营管理类占比最多占50.7%，其次是生物/制药/化工/环保类占42.7%. What education can get in at 首药控股? 本科占比最多占44%，其次是博士占32%. High education required at 首药控股? 博士占32%，硕士占18.7%. Work experience required at 首药控股? 5-10年占比最多占44%，其次是不限占25.3%. Where are the job locations at 首药控股? 北京占比最多占96%，其次是成都占2.7%. Based on job postings from the past year, for reference only.